The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension
نویسندگان
چکیده
The BREELIB nebulizer was developed for iloprost to reduce inhalation times for patients with pulmonary arterial hypertension (PAH). This multicenter, randomized, unblinded, four-part study compared inhalation time, pharmacokinetics, and acute tolerability of iloprost 5 µg at mouthpiece delivered via BREELIB versus the standard I-Neb nebulizer in 27 patients with PAH. The primary safety outcome was the proportion of patients with a maximum increase in heart rate (HR) ≥ 25% and/or a maximum decrease in systolic blood pressure ≥ 20% within 30 min after inhalation. Other safety outcomes included systolic, diastolic, and mean blood pressure, HR, oxygen saturation, and adverse events (AEs). Median inhalation times were considerably shorter with BREELIB versus I-Neb (2.6 versus 10.9 min; n = 24). Maximum iloprost plasma concentration and systemic exposure (area under the plasma concentration-time curve) were 77% and 42% higher, respectively, with BREELIB versus I-Neb. Five patients experienced a maximum systolic blood pressure decrease ≥ 20%, four with BREELIB (one mildly and transiently symptomatic), and one with I-Neb; none required medical intervention. AEs reported during the study were consistent with the known safety profile of iloprost. The BREELIB nebulizer offers reduced inhalation time, good tolerability, and may improve iloprost aerosol therapy convenience and thus compliance for patients with PAH.
منابع مشابه
5.01.522 Advanced Therapies for Pharmacological Treatment of Pulmonary Arterial Hypertension
The following therapies may be considered medically necessary for the treatment of pulmonary arterial hypertension (PAH/ WHO Group 1): ambrisentan (LETAIRIS®) oral; bosentan (TRACLEER®) oral; epoprostenol sodium (e.g., FLOLAN®) continuous IV infusion; Iloprost (VENTAVIS®) Inhalation via nebulizer; macitentan (OPSUMIT®) oral; riociguat (ADEMPAS®) oral; sildenafil citrate (e.g., REV...
متن کامل5.01.522 Advanced Therapies for Pharmacological Treatment of Pulmonary Arterial Hypertension
The following therapies may be considered medically necessary for the treatment of pulmonary arterial hypertension (PAH/ WHO Group 1): ambrisentan (LETAIRIS®) oral; bosentan (TRACLEER®) oral; epoprostenol sodium (e.g., FLOLAN®) continuous IV infusion; Iloprost (VENTAVIS®) Inhalation via nebulizer; macitentan (OPSUMIT®) oral; riociguat (ADEMPAS®) oral; sildenafil citrate (e.g., REV...
متن کاملPharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.
BACKGROUND Inhalation of iloprost, a stable prostacyclin analog, is an effective therapy for pulmonary hypertension with few side effects. This approach may, however, be handicapped by limitations of currently available nebulization devices. We assessed whether the physical characterization of a device is sufficient to predict drug deposition and pharmacologic effects. METHODS We investigated...
متن کاملAerosolized iloprost customized for the critically ill.
BACKGROUND Aerosolized iloprost, an inhaled synthetic analogue of prostacyclin, is an approved therapy for stage III and IV pulmonary hypertension. However, currently iloprost is delivered via a device that requires a clinically stable patient who can use a hand-held nebulizer. We designed separate aerosol delivery systems to nebulize iloprost to critically ill patients during (1) mechanical ve...
متن کاملEfficacy of inhaled iloprost in the management of pulmonary hypertension after cardiopulmonary bypass in infants undergoing congenital heart surgery. A case series of 31 patients
INTRODUCTION Reactive pulmonary hypertension is frequent in children with high pulmonary flow and pressure. Inhaled iloprost and nitric oxide are the only substances approved as selective pulmonary vasodilators, but data about the effectiveness and safety of inhaled iloprost during cardiac surgery in infants and children are limited. METHODS We retrospectively analysed the effects of inhaled ...
متن کامل